FDA issues guidance on public comment procedures at advisory committee meetings
The U.S. Food and Drug Administration today issued final guidance for people who wish to comment during the agency s advisory committee meetings. The guidance provides instructions on how to request a time to speak and how FDA staff should respond to requests to speak at the meetings. (PCE)